Global Toxocariasis Treatment Market, By Treatment (Anthelmintics, Corticosteroids, Anti-inflammatory Drugs, Surgery, Others), Diagnosis (Blood Tests, Laboratory Tests, Others), Dosage (Tablet, Injection, Others), Route of Administration (Oral, Intravenous, Others), Symptoms (Fever, Headache, Swollen Glands, Belly Pain, Wheezing, Vision Problems, Seizures, Loss of Appetite, Rashes, Enlarged Liver, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Global Toxocariasis Treatment Market
Toxocariasis treatment market is expected to gain market growth in the forecast period of 2021-2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 4.40% in the above mentioned forecast period.
Toxocariasis is a rare, parasitic disease which develops in humans due to the infection caused by larvae of roundworm parasites. These roundworm parasites are Toxocara canis or Toxocara cati which are usually found in the intestine of dogs, foxes and cats. Humans get this infection from handling the soil or sand contaminated with the faeces of infected animals. Symptoms of this disease includes fever, headache, swollen glands, belly pain, wheezing, vision problems, seizures, loss of appetite, rashes, enlarged liver and pain in the eyes.
Rise in the prevalence of toxocariasis, growing healthcare expenditure, development of treatment options, growing government funding, poor hygiene, rising initiatives to spread awareness about the proper care of pet animals are the factors that will expand the toxocariasis treatment market.
Rise in the research and development activities and emerging markets will provide beneficial opportunities for the toxocariasis treatment market in the forecast period of 2021-2028.
However, high cost of treatment and side effects associated with the medication are the factors that will hinder the market growth. Lack of awareness about the preventive measures will challenge the toxocariasis treatment market in the forecast period mentioned above.
This toxocariasis treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the toxocariasis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Toxocariasis Treatment Market Scope and Market Size
The toxocariasis treatment market is segmented on the basis of treatment, diagnosis, dosage, route of administration, symptoms, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of treatment, the toxocariasis treatment market is segmented into anthelmintics, corticosteroids, anti-inflammatory drugs, surgery and others. Anthelmintics have been further sub-segmented into mebendazole, albendazole, diethylcarbamazine and others.
- On the basis of diagnosis, the toxocariasis treatment market is segmented into blood tests, laboratory tests and others.
- On the basis of dosage, the toxocariasis treatment market is segmented into tablet, injection and others.
- On the basis of route of administration, the toxocariasis treatment market is segmented into oral, intravenous and others.
- On the basis of symptoms, the toxocariasis treatment market is segmented into fever, headache, swollen glands, belly pain, wheezing, vision problems, seizures, loss of appetite, rashes, enlarged liver and others.
- On the basis of end-users, the toxocariasis treatment market is segmented into clinic, hospital and others.
The toxocariasis treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Toxocariasis Treatment Market Country Level Analysis
Toxocariasis treatment market is analyzed and market size information is provided by the country, treatment, diagnosis, dosage, route of administration, symptoms, end-users and distribution channel as referenced above.
The countries covered in the toxocariasis treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the toxocariasis treatment market due to the presence of major key players, growing investment for R&D activities, high disposable income, high healthcare expenditure and well-developed healthcare sector in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Toxocariasis treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Toxocariasis Treatment Market Share Analysis
Toxocariasis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global toxocariasis treatment market research.
The major players covered in the toxocariasis treatment market report are Allergan, Merck Sharp & Dohme Corp., Pfizer Inc., GlaxoSmithKline plc, Sanofi, Cipla Inc., AstraZeneca, Johnson & Johnson Private Limited, Mylan N.V., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Bristol-Myers Squibb Company, Novartis AG, Accord Healthcare, F. Hoffmann-La Roche Ltd., AbbVie Inc., Abbott, Bayer AG, Sumitomo Corporation, Merck KGaA, LEO Pharma A/S, Bausch Health Companies Inc., Assertio Holdings, Inc., Boehringer Ingelheim International GmbH., and Horizon Therapeutics plc, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-